The increased put options activity for Rain Oncology suggests that investors may be expecting the stock price to decline in the short term. This bearish sentiment could be driven by various factors, including the upcoming earnings release on August 3. The close proximity of the number of contracts to the open interest also indicates that this options activity is significant and could impact the stock price.